RANDI THOMPSON, O.D.
Corneal and Contact Management Optometrist in ALBUQUERQUE, New Mexico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
RANDI THOMPSON, O.D. reported a CMS MIPS final score of 93.5416/100 — above the 83.1 national average — and filed 617 Medicare Part D claims in 2023.
- 93.5416/100
- MIPS score · +10 vs avg
- 617
- Part D claims, 2023
- 54%
- generic prescribing
- $19.93
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
RANDI THOMPSON, O.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
94 Top 29% higher than 71% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about RANDI THOMPSON, O.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Corneal and Contact Management Optometrist compares to other specialties among New Mexico providers
Corneal and Contact Management Optometrist share within New Mexico
Corneal and Contact Management Optometrist is one of the more visible NUCC categories in New Mexico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RANDI THOMPSON, O.D.'s 2023 MIPS final score plotted against the Corneal and Contact Management Optometrist national average
- MIPS Final Score
- 93.5416/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Corneal and Contact Management Optometrist) — 93.5416/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Corneal and Contact Management Optometrist US NPIs
93.5416/100 MIPS final score — 10.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Corneal and Contact Management Optometrist. Quality dim: 93.2189. Cost dim: 63.8307.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RANDI THOMPSON, O.D. is a Corneal and Contact Management Optometrist provider practicing in ALBUQUERQUE, New Mexico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1679553234. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RANDI THOMPSON, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 1600 UNIVERSITY BLVD NE, ALBUQUERQUE, NM, 87102, with a listed phone of (505) 272-2553. NPI 1679553234 was issued on 01/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what THOMPSON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 617 prescription claims written by this provider, covering 184 Medicare beneficiaries and totaling roughly $154K in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.5416/100 for the 2023 performance year (Quality 93.2189, Cost 63.8307), compared with the national average of 83.1.
Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1679553234 |
|---|---|
| Specialty | Corneal and Contact Management Optometrist |
| Credentials | O.D. |
| Gender | Female |
| NPI Issued | 01/19/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RANDI THOMPSON, O.D.'s current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RANDI THOMPSON, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$20
Largest payer
Tarsus Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
46% brand-name claims vs 54% generic, on 617 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 902
- Total Day Supply
- 25,078
- Brand vs Generic
- 46% brand / 54% generic
- Brand Drug Cost
- $143K
- Generic Drug Cost
- $11K
Patient Demographics
- Average Patient Age
- 71.5 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 30, 65-74: 89, 75-84: 53, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 268 |
| Restasis Cyclosporine | 90 |
| Xiidra Lifitegrast | 47 |
| Erythromycin Erythromycin Base | 33 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 27 |
| Cyclosporine | 23 |
| Timolol Maleate | 17 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 15 |
| Brimonidine Tartrate | 13 |
| Pilocarpine Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Corneal and Contact Management Optometrist Overview
How RANDI THOMPSON, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.
RANDI THOMPSON, O.D.'s 617 claims are above the specialty average of 235.
Nearby Corneal and Contact Management Optometrist Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as THOMPSON.
Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Mexico
Frequently Asked Questions
What is RANDI THOMPSON, O.D.'s specialty? ▼
How much does RANDI THOMPSON, O.D. prescribe under Medicare Part D? ▼
What is RANDI THOMPSON, O.D.'s Medicare quality score? ▼
Where is RANDI THOMPSON, O.D. located? ▼
What is RANDI THOMPSON, O.D.'s NPI number? ▼
Does RANDI THOMPSON, O.D. prescribe more brand-name or generic drugs? ▼
How many Corneal and Contact Management Optometrist providers are there in the US? ▼
What drugs does RANDI THOMPSON, O.D. prescribe most often? ▼
Does RANDI THOMPSON, O.D. accept Medicare? ▼
How can I verify RANDI THOMPSON, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology